Optiscan Biomedical Corp. has received 510(k) clearance for its Optiscanner 5000 glucose monitoring system. The clearance allows the device to be used for monitoring plasma glucose levels and determining dysglycemia in surgical intensive care unit (ICU) patients. Read More
